Description

Regulatory Panel Session: Drug Shortages and COVID-19 |

Speaker(s):

• Stephanie Croft, Technical Officer Inspection Services - Prequalification Team, World Health Organization
• Domenico Di Giorgio, Director, Inspection & Certification Department, AIFA Agenzia Italiana Del Farmaco
• Simeon Gill, Pharmaceutical Assessor Biologics Unit, Licensing Division MHRA, MHRA
• Manuel Ibarra, Head of Pharmaceutical Inspection & Enforcement Department, Spanish Agency of Medicines and Healthcare Products
• Jacques Morenas, Technical Advisor of the Inspection Division Director, ANSM (Agence Nationale De Securite Du Medicament Et Des Produits De Sante)
• Carmelo Rosa, PsyD, Director, Division of Drug Quality I, FDA/CDER/OC/OMQ